Leading Pharmaceutical and Biopharmaceutical Company | Pfizer

 

Our Purpose

Traveling 9,000 Miles to Help End Trachoma

Antibiotics are a key component in the global effort to eliminate trachoma, the world’s leading infectious cause of blindness.

Read More
Our Science

Chemical Compounds to Advance Drug Synthesis

In its Mr. Hyde form of a colorless, odorless gas, sulfuryl fluoride is used extensively as a fumigant in pest control.

Read More
Your Health

Summer Food Safety Fact and Fiction

According to the USDA, summer sees a spike in food-borne illnesses due to improper handling and serving.

Read More
Your Health

Is Sitting Behind Your Desk Bad for Your Health?

If you sit for long periods of time each day working on a computer, you may be at risk for developing physical strain and overuse injuries.

Learn More

Find a Trial

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your zip code, city, or country to find studies near you.
Advanced Search
Our Science

How to Deal Dangerous Proteins a Knockout Blow

Getting rid of a problematic protein, however, isn’t easy. Since DNA and RNA contain the code for creating individual proteins, scientists long focused on these two nucleic acids as the key to purging proteins.

Learn More
Your Health

Here Are 5 Ways to Combat Mental Fatigue

When someone learns they have a chronic disease, whether it’s arthritis, diabetes, irritable bowel syndrome or another condition, it can be a life-altering experience.

Learn More
Latest news
XELJANZ® (tofacitinib citrate) Receives Marketing...

Pfizer Inc. (NYSE:PFE) announced today that the European Commission (EC) has approved XELJANZ® (tofacitinib citrate) 10 mg twice-daily (BID) for at least eight weeks, followed by XELJANZ 5 mg BID or 10 mg BID, for the treatment of adult patients with moderately to...

Read more